Repertoire of microglial and macrophage responses after spinal cord injury

Nature Reviews Neuroscience

Volumn 12, Issue 7, 2011, Pages 388-399

  David, Samuel ^a   Kroner, Antje ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD163 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CX3CR1; COLONY STIMULATING FACTOR 1; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNINDEXED DRUG;

CELL DIFFERENTIATION; CELL SURVIVAL; DENDRITIC CELL; HUMAN; INFLAMMATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MONOCYTE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SPINAL CORD INJURY;

ANIMALS; CELL POLARITY; HUMANS; INFLAMMATION; MACROPHAGES; MICROGLIA; MODELS, BIOLOGICAL; SPINAL CORD INJURIES;

EID: 79959379095     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3053     Document Type: Review

References (165)

1. Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845 (2010).
2. Yong, V. W. & Rivest, S. Taking advantage of the systemic immune system to cure brain diseases. Neuron 64, 55-60 (2009).
3. Dai, X. M. et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111-120 (2002).
4. Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003). (Pubitemid 36859902)
5. Fogg, D. K. et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83-87 (2006). (Pubitemid 43063063)
6. Naik, S. H. et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nature Immunol. 7, 663-671 (2006). (Pubitemid 43797348)
7. Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A. & Pamer, E. G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19, 59-70 (2003). (Pubitemid 36859901)
8. Auffray, C. et al. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med. 206, 595-606 (2009).
9. Ginhoux, F. et al. Langerhans cells arise from monocytes in vivo. Nature Immunol. 7, 265-273 (2006).
10. Landsman, L. & Jung, S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J. Immunol. 179, 3488-3494 (2007).
11. Landsman, L., Varol, C. & Jung, S. Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol. 178, 2000-2007 (2007). (Pubitemid 46233396)
12. Varol, C. et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204, 171-180 (2007). (Pubitemid 46148767)
13. Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nature Med. 11, 328-334 (2005). (Pubitemid 40460562)
14. King, I. L., Dickendesher, T. L. & Segal, B. M. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113, 3190-3197 (2009).
15. Pineau, I., Sun, L., Bastien, D. & Lacroix, S. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav. Immun. 24, 540-553 (2010).
16. Sroga, J. M., Jones, T. B., Kigerl, K. A., McGaughy, V. M. & Popovich, P. G. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. 462, 223-240 (2003). (Pubitemid 36723670)
17. Donnelly, D. J. & Popovich, P. G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 209, 378-388 (2008). (Pubitemid 351181428)
18. Fleming, J. C. et al. The cellular inflammatory response in human spinal cords after injury. Brain 129, 3249-3269 (2006). (Pubitemid 44871440)
19. Schwab, J. M. & Serhan, C. N. Lipoxins and new lipid mediators in the resolution of inflammation. Curr. Opin. Pharmacol. 6, 414-420 (2006).
20. Schwab, J. M., Chiang, N., Arita, M. & Serhan, C. N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874 (2007). (Pubitemid 46920139)
21. Prüss, H. et al. Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau. Brain Pathol. 24 Apr 2011 (doi:10.1111/j.1750-3639.2011.00488.x).
22. Huang, W. L. et al. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 130, 3004-3019 (2007). (Pubitemid 350033967)
23. King, V. R. et al. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 26, 4672-4680 (2006). (Pubitemid 44315368)
24. Ward, R. E., Huang, W., Curran, O. E., Priestley, J. V. & Michael-Titus, A. T. Docosahexaenoic acid prevents white matter damage after spinal cord injury. J. Neurotrauma 27, 1769-1780 (2010).
25. Lim, S. N. et al. The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot. Essent. Fatty Acids 83, 193-201 (2010).
26. López-Vales, R. et al. Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. J. Neurosci. 30, 3220-3226 (2010).
27. Huang, B. et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123-1131 (2006). (Pubitemid 43165981)
28. Rodrigues, J. C. et al. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol. 12, 351-365 (2010).
29. Sunderkotter, C. et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172, 4410-4417 (2004). (Pubitemid 38375256)
30. Auffray, C. et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670 (2007). (Pubitemid 47229966)
31. Auffray, C., Sieweke, M. H. & Geissmann, F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692 (2009).
32. Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037-3047 (2007). (Pubitemid 350179569)
33. Geissmann, F. et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 86, 398-408 (2008). (Pubitemid 351948210)
34. Kobayashi, M. et al. M2b monocytes predominated in peripheral blood of severely burned patients. J. Immunol. 185, 7174-7179 (2010).
35. London, A. et al. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J. Exp. Med. 208, 23-39 (2011).
36. Shechter, R. et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6, e1000113 (2009).
37. Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neurosci. 8, 752-758 (2005). (Pubitemid 43085841)
38. Hines, D. J., Hines, R. M., Mulligan, S. J. & Macvicar, B. A. Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia 57, 1610-1618 (2009).
39. Haynes, S. E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nature Neurosci. 9, 1512-1519 (2006). (Pubitemid 44862659)
40. Wu, L. J., Vadakkan, K. I. & Zhuo, M. ATP-induced chemotaxis of microglial processes requires P2Y receptor-activated initiation of outward potassium currents. Glia 55, 810-821 (2007). (Pubitemid 46787192)
41. Ohsawa, K. et al. P2Y12 receptor-mediated integrin-β1 activation regulates microglial process extension induced by ATP. Glia 58, 790-801 (2010).
42. Franke, H. et al. P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo. Glia 57, 1031-1045 (2009).
43. Irino, Y., Nakamura, Y., Inoue, K., Kohsaka, S. & Ohsawa, K. Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia. J. Neurosci. Res. 86, 1511-1519 (2008). (Pubitemid 351642444)
44. Liang, K. J. et al. Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling. Invest. Ophthalmol. Vis. Sci. 50, 4444-4451 (2009).
45. Dibaj, P. et al. NO mediates microglial response to acute spinal cord injury under ATP control in vivo. Glia 58, 1133-1144 (2010).
46. Ransohoff, R. M. & Perry, V. H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145 (2009).
47. Perry, V. H., Cunningham, C. & Holmes, C. Systemic infections and inflammation affect chronic neurodegeneration. Nature Rev. Immunol. 7, 161-167 (2007). (Pubitemid 46174862)
48. Zhang, J. et al. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J. Neurosci. 27, 12396-12406 (2007). (Pubitemid 350085465)
49. Deng, Y. Y., Lu, J., Ling, E. A. & Kaur, C. Monocyte chemoattractant protein-1 (MCP-1) produced via NF-κB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats. Glia 57, 604-621 (2009).
50. Schwab, J. M. et al. AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J. Neuroimmunol. 119, 214-222 (2001). (Pubitemid 32918329)
51. Ip, C. W. et al. Origin of CD11b+ macrophage-like cells in the CNS of PLP-overexpressing mice: low influx of haematogenous macrophages and unchanged blood-brain-barrier in the optic nerve. Mol. Cell Neurosci. 38, 489-494 (2008).
52. Ip, C. W. et al. Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J. Neurosci. 26, 8206-8216 (2006). (Pubitemid 44315145)
53. Ip, C. W., Kroner, A., Crocker, P. R., Nave, K. A. & Martini, R. Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol. Dis. 25, 105-111 (2007). (Pubitemid 44765220)
54. Schonrock, L. M., Kuhlmann, T., Adler, S., Bitsch, A. & Bruck, W. Identification of glial cell proliferation in early multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 24, 320-330 (1998). (Pubitemid 28389129)
55. Imamoto, K. & Leblond, C. P. Presence of labeled monocytes, macrophages and microglia in a stab wound of the brain following an injection of bone marrow cells labeled with 3H-uridine into rats. J. Comp. Neurol. 174, 255-279 (1977). (Pubitemid 8120313)
56. Popovich, P. G. & Hickey, W. F. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J. Neuropathol. Exp. Neurol. 60, 676-685 (2001). (Pubitemid 32619790)
57. Popovich, P. G. et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158, 351-365 (1999). (Pubitemid 29382826)
58. Bendszus, M. & Stoll, G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J. Neurosci. 23, 10892-10896 (2003). (Pubitemid 37499698)
59. Horky, L. L., Galimi, F., Gage, F. H. & Horner, P. J. Fate of endogenous stem/progenitor cells following spinal cord injury. J. Comp. Neurol. 498, 525-538 (2006). (Pubitemid 44232692)
60. Imai, M. et al. Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model. J. Neurosurg. Spine 8, 58-66 (2008).
61. Pineau, I. & Lacroix, S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500, 267-285 (2007). (Pubitemid 44937122)
62. Yang, L. et al. Early expression and cellular localization of proinflammatory cytokines interleukin-1β, interleukin-6, and tumor necrosis factor-α in human traumatic spinal cord injury. Spine 29, 966-971 (2004). (Pubitemid 38580232)
63. Nesic, O. et al. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J. Neurotrauma 18, 947-956 (2001). (Pubitemid 32852894)
64. Yang, L. et al. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J. Clin. Neurosci. 12, 276-284 (2005). (Pubitemid 40585726)
65. Ferguson, A. R. et al. Cell death after spinal cord injury is exacerbated by rapid TNF α-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J. Neurosci. 28, 11391-11400 (2008).
66. Probert, L. et al. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123 (Pt 10), 2005-2019 (2000).
67. Genovese, T. et al. TNF-α blockage in a mouse model of SCI: evidence for improved outcome. Shock 29, 32-41 (2008).
68. Letellier, E. et al. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 32, 240-252 (2010).
69. Lσpez-Vales, R. et al. FK 506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. J. Neurosci. Res. 81, 827-836 (2005). (Pubitemid 41532148)
70. Stirling, D. P. et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24, 2182-2190 (2004). (Pubitemid 38314550)
71. Iannotti, C. A. et al. A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI. Exp. Neurol. 23 Mar 2010 (doi:10.1016/j.expneurol.2010.03.010).
72. Thuraisingam, T. et al. Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands. Mol. Immunol. 44, 3482-3491 (2007). (Pubitemid 46754448)
73. Kaushal, V., Koeberle, P. D., Wang, Y. & Schlichter, L. C. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J. Neurosci. 27, 234-244 (2007). (Pubitemid 46089977)
74. Kaushal, V. & Schlichter, L. C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 28, 2221-2230 (2008). (Pubitemid 351317617)
75. Chatzipanteli, K. et al. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment. J. Neurotrauma 19, 639-651 (2002). (Pubitemid 34587306)
76. Lσpez-Vales, R., Garcia-Alias, G., Fores, J., Navarro, X. & Verdu, E. Increased expression of cyclo-oxygenase 2 and vascular endothelial growth factor in lesioned spinal cord by transplanted olfactory ensheathing cells. J. Neurotrauma 21, 1031-1043 (2004). (Pubitemid 39096853)
77. Pearse, D. D., Chatzipanteli, K., Marcillo, A. E., Bunge, M. B. & Dietrich, W. D. Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury. J. Neuropathol. Exp. Neurol. 62, 1096-1107 (2003). (Pubitemid 37413821)
78. Cardona, A. E. et al. Control of microglial neurotoxicity by the fractalkine receptor. Nature Neurosci. 9, 917-924 (2006). (Pubitemid 43980506)
79. Denes, A., Ferenczi, S., Halasz, J., Kornyei, Z. & Kovacs, K. J. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 28, 1707-1721 (2008).
80. Soriano, S. G. et al. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125, 59-65 (2002). (Pubitemid 34327454)
81. Lee, S. et al. CX3CR1 deficiency alters microglial activation and reduces β-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 177, 2549-2562 (2010).
82. Arnett, H. A. et al. TNF α promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neurosci. 4, 1116-1122 (2001). (Pubitemid 34116557)
83. Takahashi, K., Rochford, C. D. & Neumann, H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201, 647-657 (2005). (Pubitemid 40289554)
84. Fry, E. J., Ho, C. & David, S. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 53, 649-662 (2007). (Pubitemid 46283376)
85. Satoh, J., Onoue, H., Arima, K. & Yamamura, T. Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J. Neuropathol. Exp. Neurol. 64, 129-138 (2005). (Pubitemid 40349311)
86. David, S., Fry, E. J. & Lopez-Vales, R. Novel roles for Nogo receptor in inflammation and disease. Trends Neurosci. 31, 221-226 (2008).
87. Lu, Y. Z., Lin, C. H., Cheng, F. C. & Hsueh, C. M. Molecular mechanisms responsible for microglia-derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci. Lett. 373, 159-164 (2005).
88. Wiessner, C. et al. Expression of transforming growth factor-β 1 and interleukin-1 β mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol. 86, 439-446 (1993).
89. Mitrasinovic, O. M. et al. Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial- hippocampal organotypic coculture system. J. Neurosci. 25, 4442-4451 (2005). (Pubitemid 40628788)
90. Lambert, C. et al. Dendritic cell differentiation signals induce anti-inflammatory properties in human adult microglia. J. Immunol. 181, 8288-8297 (2008).
91. Bouhy, D. et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J. 20, 1239-1241 (2006).
92. Ha, Y. et al. Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J. Neurosurg. Spine 2, 55-61 (2005).
93. Rapalino, O. et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nature Med. 4, 814-821 (1998). (Pubitemid 28331023)
94. Schwartz, M. et al. Potential repair of rat spinal cord injuries using stimulated homologous macrophages. Neurosurgery 44, 1041-1045; discussion 1045-1046 (1999).
95. Lazarov-Spiegler, O. et al. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 10, 1296-1302 (1996). (Pubitemid 26307515)
96. Lazarov-Spiegler, O., Solomon, A. S. & Schwartz, M. Peripheral nerve-stimulated macrophages simulate a peripheral nerve-like regenerative response in rat transected optic nerve. Glia 24, 329-337 (1998). (Pubitemid 28465980)
97. Leon, S., Yin, Y., Nguyen, J., Irwin, N. & Benowitz, L. I. Lens injury stimulates axon regeneration in the mature rat optic nerve. J. Neurosci. 20, 4615-4626 (2000). (Pubitemid 30396627)
98. Yin, Y. et al. Macrophage-derived factors stimulate optic nerve regeneration. J. Neurosci. 23, 2284-2293 (2003). (Pubitemid 36368916)
99. Yin, Y. et al. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nature Neurosci. 9, 843-852 (2006).
100. Paludan, S. R. Interleukin-4 and interferon-γ: the quintessence of a mutual antagonistic relationship. Scand. J. Immunol. 48, 459-468 (1998). (Pubitemid 28505668)
101. Standiford, T. J. et al. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol. 145, 1435-1439 (1990). (Pubitemid 20255050)
102. Tanaka, T., Hu-Li, J., Seder, R. A., Fazekas de St Groth, B. & Paul, W. E. Interleukin 4 suppresses interleukin 2 and interferon γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl Acad. Sci. USA 90, 5914-5918 (1993). (Pubitemid 23191424)
103. Wynn, T. A. IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456 (2003). (Pubitemid 37174537)
104. Wynn, T. A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nature Rev. Immunol. 4, 583-594 (2004).
105. Gordon, S. & Taylor, P. R. Monocyte and macrophage heterogeneity. Nature Rev. Immunol. 5, 953-964 (2005). (Pubitemid 41746764)
106. Martinez, F. O., Helming, L. & Gordon, S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483 (2009).
107. Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature Immunol. 11, 889-896 (2010).
108. Mantovani, A. & Locati, M. Orchestration of macrophage polarization. Blood 114, 3135-3136 (2009).
109. Sica, A. et al. Macrophage polarization in tumour progression. Semin. Cancer Biol. 18, 349-355 (2008).
110. Longbrake, E. E., Lai, W., Ankeny, D. P. & Popovich, P. G. Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J. Neurochem. 102, 1083-1094 (2007). (Pubitemid 47174229)
111. Kigerl, K. A. et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435-13444 (2009).
112. Ghasemlou, N. et al. Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury. Brain 133, 126-138 (2010).
113. Ghasemlou, N. et al. Mitogen-activated protein kinase-activated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury. J. Neurosci. 30, 13750-13759 (2010).
114. Kerr, B. J., Girolami, E. I., Ghasemlou, N., Jeong, S. Y. & David, S. The protective effects of 15-deoxy-δ-(12, 14)-prostaglandin J2 in spinal cord injury. Glia 56, 436-448 (2008). (Pubitemid 351212952)
115. Lopez-Vales, R. et al. Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. J. Neurosci. 30, 3220-3226 (2010).
116. Redensek, A. et al. Expression and detrimental role of hematopoietic prostaglandin D synthase in spinal cord contusion injury. Glia 59, 603-614 (2011).
117. Nishio, Y. et al. Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice. Acta Neuropathol. 117, 321-328 (2009).
118. Bao, F. et al. Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Exp. Neurol. 215, 308-316 (2009).
119. Bao, F., Chen, Y., Dekaban, G. A. & Weaver, L. C. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J. Neurochem. 88, 1335-1344 (2004). (Pubitemid 38366908)
120. Rathore, K. I. et al. Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage. J. Neurosci. 28, 12736-12747 (2008).
121. Mikita, J. et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 17, 2-15 (2011).
122. Berard, J. L., Kerr, B. J., Johnson, H. M. & David, S. Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity. Glia 58, 1816-1826 (2010).
123. Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311 (2006). (Pubitemid 44715100)
124. Bradbury, E. J. et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640 (2002). (Pubitemid 34406764)
125. Busch, S. A. & Silver, J. The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol. 17, 120-127 (2007). (Pubitemid 46227979)
126. Galtrey, C. M. & Fawcett, J. W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 54, 1-18 (2007). (Pubitemid 46498163)
127. Moon, L. D., Asher, R. A., Rhodes, K. E. & Fawcett, J. W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nature Neurosci. 4, 465-466 (2001). (Pubitemid 32397182)
128. Busch, S. A., Horn, K. P., Silver, D. J. & Silver, J. Overcoming macrophage-mediated axonal dieback following CNS injury. J. Neurosci. 29, 9967-9976 (2009).
129. Horn, K. P., Busch, S. A., Hawthorne, A. L., van Rooijen, N. & Silver, J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J. Neurosci. 28, 9330-9341 (2008).
130. Hata, K. et al. RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J. Cell Biol. 173, 47-58 (2006).
131. Schwab, J. M. et al. Spinal cord injury-induced lesional expression of the repulsive guidance molecule (RGM). Eur. J. Neurosci. 21, 1569-1576 (2005). (Pubitemid 40646602)
132. Boven, L. A. et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129, 517-526 (2006). (Pubitemid 43164373)
133. van Rossum, D., Hilbert, S., Strassenburg, S., Hanisch, U. K. & Bruck, W. Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 56, 271-283 (2008).
134. Ponomarev, E. D., Maresz, K., Tan, Y. & Dittel, B. N. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J. Neurosci. 27, 10714-10721 (2007). (Pubitemid 47535871)
135. Pechkovsky, D. V. et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin. Immunol. 137, 89-101 (2010).
136. Misson, P., van den Brule, S., Barbarin, V., Lison, D. & Huaux, F. Markers of macrophage differentiation in experimental silicosis. J. Leukoc. Biol. 76, 926-932 (2004). (Pubitemid 39458704)
137. Ikezumi, Y. et al. Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion. Histopathology 58, 198-210 (2011).
138. Bellon, T. et al. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Nephrol. Dial. Transplant 15 Feb 2011 (doi:10.1093/ndt/gfq771).
139. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555 (2002). (Pubitemid 35223554)
140. Gratchev, A. et al. Activation of a TGF-β-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-β receptor II. J. Immunol. 180, 6553-6565 (2008).
141. Ganz, T. Hepcidin-a peptide hormone at the interface of innate immunity and iron metabolism. Curr. Top. Microbiol. Immunol. 306, 183-198 (2006). (Pubitemid 47400322)
142. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093 (2004). (Pubitemid 40007660)
143. Sindrilaru, A. et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Invest. 121, 985-997 (2011).
144. Bellora, F. et al. The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc. Natl Acad. Sci. USA 107, 21659-21664 (2010).
145. Sironi, M. et al. Differential regulation of chemokine production by Fcγ receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J. Leukoc. Biol. 80, 342-349 (2006). (Pubitemid 44835507)
146. Ziegler-Heitbrock, H. W. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol. Today 17, 424-428 (1996). (Pubitemid 26278368)
147. Mildner, A. et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nature Neurosci. 10, 1544-1553 (2007). (Pubitemid 350175884)
148. Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686 (2004). (Pubitemid 39457982)
149. Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453-461 (2008). (Pubitemid 351599757)
150. Stein, M., Keshav, S., Harris, N. & Gordon, S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292 (1992).
151. Gratchev, A. et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3. Scand. J. Immunol. 53, 386-392 (2001). (Pubitemid 32275696)
152. Hesse, M. et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167, 6533-6544 (2001). (Pubitemid 33081589)
153. Gordon, S. Alternative activation of macrophages. Nature Rev. Immunol. 3, 23-35 (2003). (Pubitemid 37328697)
154. Raes, G. et al. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 174, 6561; author reply 6561-6562 (2005).
155. Scotton, C. J. et al. Transcriptional profiling reveals complex regulation of the monocyte IL-1 β system by IL-13. J. Immunol. 174, 834-845 (2005). (Pubitemid 40103564)
156. Villalta, S. A., Nguyen, H. X., Deng, B., Gotoh, T. & Tidball, J. G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 18, 482-496 (2009).
157. Goerdt, S. & Orfanos, C. E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142 (1999). (Pubitemid 29115619)
158. Anderson, C. F. & Mosser, D. M. Cutting edge: biasing immune responses by directing antigen to macrophage Fc γ receptors. J. Immunol. 168, 3697-3701 (2002). (Pubitemid 34298366)
159. Anderson, C. F. & Mosser, D. M. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol. 72, 101-106 (2002).
160. Mosser, D. M. The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212 (2003). (Pubitemid 36158295)
161. Filardy, A. A. et al. Proinflammatory clearance of apoptotic neutrophils induces an IL-12lowIL-10high regulatory phenotype in macrophages. J. Immunol. 185, 2044-2050 (2010).
162. Gea-Sorli, S., Guillamat, R., Serrano-Mollar, A. & Closa, D. Activation of lung macrophage subpopulations in experimental acute pancreatitis. J. Pathol. 223, 417-424 (2011).
163. Bogdan, C., Paik, J., Vodovotz, Y. & Nathan, C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267, 23301-23308 (1992).
164. Valledor, A. F. & Ricote, M. Nuclear receptor signaling in macrophages. Biochem. Pharmacol. 67, 201-212 (2004). (Pubitemid 38112751)
165. Ehrchen, J. et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109, 1265-1274 (2007). (Pubitemid 46220679)